Mankind Pharma (NSE:MANKIND) Buildings And Improvements : ₹0 Mil (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Buildings And Improvements?

Mankind Pharma's annual buildings and improvements increased from Mar. 2023 (₹10,690 Mil) to Mar. 2024 (₹12,792 Mil) but then declined from Mar. 2024 (₹12,792 Mil) to Mar. 2025 (₹0 Mil).

Mankind Pharma Buildings And Improvements Historical Data

The historical data trend for Mankind Pharma's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Buildings And Improvements Chart

Mankind Pharma Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Buildings And Improvements

Get a 7-Day Free Trial

5,889.71

6,014.21

10,689.63

12,791.76

Mankind Pharma Quarterly Data
	Mar20	Mar21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial										12,791.76	-	-	-	-

Mankind Pharma Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Mankind Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (NSE:MANKIND) » Definitions » Buildings And Improvements

Traded in Other Exchanges

543904:India

Address

262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020

Website

https://www.mankindpharma.com

Mankind Pharma Ltd is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors providing products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News, Gas-O-Fast, AcneStar and HealthOK. Geographically, the company derives a majority of its revenue from the sale of pharmaceutical products in India and the rest from its customers located outside India.

Mankind Pharma Headlines

No Headlines